December 17, 2019 / 9:00 PM / a month ago

FTC files complaint to block Illumina from buying PacBio

WASHINGTON, Dec 17 (Reuters) - The Federal Trade Commission has filed a complaint aimed at stopping Illumina Inc from purchasing Pacific Biosciences of California, the agency said on Tuesday.

The agency said in a statement that it had filed the complaint because of concern that Illumina sought to buy PacBio in order to prevent PacBio from developing into a competitor to Illumina in the market for next-generation DNA sequencing. (Reporting by Diane Bartz; Editing by Sandra Maler)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below